Galileo Research Facts No. 120: Can Galileo Therapy increase muscle and lung function in Cystic Fibrosis patients?

This study investigated the effects of Galileo Therapy on muscle function and lung function of adult Cystic Fibrosis (CF) patients (age 24-47). CF is a genetic disorder that typically effects the lungs for example by difficulty of breathing because of coughing up mucus. The patients received Galileo Therapy over a period of 3 Months, 2 times per day, 5 days per week, 3*3 minutes at high frequencies (20 to 25Hz).

The results of the Galileo Therapy show significant improvements of lung function by +5% (FEV, forced expiratory volume) and muscle function e.g. in the chair rising test (CRT) by +16% in muscle power and +34% in muscle force. The results of this study are in line with results of Galileo Therapy in COPD (Chronic Obstructive Pulmonary Disease, #GRFS107, #GRFS41, #GRFS34, #GRFS32) and show once more the enormous potential of Galileo as a therapy device.

#GRFS120 # GalileoTherapy #CysticFibrosis #CF #LungFunction #MuscleFunction #CRT #COPD